Introduction
Megakaryocyte maturation and platelet production are complex processes that involve cellular mechanisms unique to the lineage, including polyploidisation via nuclear replication in the absence of cellular cytokinesis, a process termed endomitosis.
Platelet shedding from megakaryocytes occurs by extension of long pseudopods, termed proplatelets, from the megakaryocyte cytoplasm, and formation of anucleate platelets by budding at the ends of these structures 1, 2 . This process requires a reserve of cytoplasmic membrane, which exists in the cytoplasm of mature megakaryocytes within a structure termed the demarcation membrane system (DMS) 3 . There is also dynamic reorganisation of the cytoskeleton, bringing about the assembly of the marginal band, a ring of microtubules primarily composed of β1-tubulin, a divergent β-tubulin isoform which is restricted to the megakaryocyte lineage and is essential for platelet discoid shape [4] [5] [6] .
The primary cytokine regulator of megakaryocyte development is thrombopoietin, which binds to its cognate receptor c-Mpl to regulate megakaryocyte development.
Thrombopoietin functions primarily at the progenitor level to promote megakaryocyte proliferation and development, however it is not required for the terminal phase of platelet shedding 7 .
Whilst the transcriptional control of platelet production is less well understood, a number of key regulators have been described including NF-E2, GATA-1, FOG-1 and
Fli-1 8 . The generation of mice lacking these genes has shed light on the transcriptional regulation of megakaryocyte development and platelet shedding. The
For personal use only. on August 16, 2017. by guest www.bloodjournal.org From 4 most important identified regulator of platelet shedding is NF-E2, as mice lacking this factor display severe thrombocytopenia (less than 5% the normal platelet count) despite increased numbers of megakaryocytes 9, 10 . NF-E2 null megakaryocytes display numerous morphologic abnormalities including an aberrant DMS, reduced cytoplasmic granules and a complete absence of proplatelet formation 11 . Several target genes of NF-E2 have been identified, including β-1 tubulin 5, 6 , Caspase 12 12 , thromboxane synthase 13 , Rab27b 14 and 3β-hydroxysteroid dehydrogenase (3β-HSD), a mediator of autocrine biosynthesis of estradiol within megakaryocytes which is absent in NF-E2 null megakaryocytes and sufficient to restore proplatelet formation when ectopically expressed in these cells 15 .
One potential regulator of NF-E2 is GATA-1. Mice lacking GATA-1 in megakaryocytes compartment display marked thrombocytopenia (around 10% of normal platelet numbers) despite grossly increased numbers of immature megakaryocytes both in vitro and in vivo 16, 17 . Similar to NF-E2 null megakaryocytes, GATA-1 null megakaryocytes display abnormal ultrastructure including a reduction in platelet granules and disorganised DMS. Transcriptional profiling has shown a reduced expression of a number of genes which are also decreased in NF-E2 null megakaryocytes, including β1-tubulin, 3β-HSD and Caspase-12 12,15,17,18 . These findings may be explained by the findings that the expression of NF-E2 is reduced in GATA-1 null megakaryocytes 17, 18 , and that efficient transcriptional activity of the major NF-E2 promoter active in the erythroid/megakaryocytic lineages requires the presence of tandem GATA motifs, implying that GATA-1 may be a regulator of NF-E2 expression in megakaryocytes 19, 20 .
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Another potential regulator of platelet production is the basic helix-loop-helix (bHLH) transcription factor Scl, the expression of which is predominantly restricted to the megakaryocyte and erythroid lineages 21 . Scl forms obligate heterodimers with ubiquitous E proteins (E12 and E47, products of the E2A gene, HEB and E2-2) which bind to E box motifs (sequence CANNTG) and mediate either transcriptional activation or repression. In erythroid cells, these heterodimers are found in larger multimeric complexes containing at least the GATA-1, Lmo2 and Ldb1 proteins which bind to bipartite E box-GATA motifs 22 . Whilst several target genes of this complex have been described in the erythroid lineage, no megakaryocytic target genes have yet been identified 23 .
Mice lacking Scl die at embryonic day 9.5 due to a complete failure of haemopoietic specification 24,25 and defective vasculogenesis 26 . To overcome this, and allow the analysis of the function of Scl in adult haemopoiesis, conditional Scl-null mice have been generated 27, 28 . Surprisingly, absence of Scl in adult haematopoiesis is not lethal although there are demonstrable effects on haematopoietic stem cell function and erythropoiesis 29, 30 . Despite this, these mice survive long-term with persistent but stable anaemia and thrombocytopenia. The aim of this study was to determine the mechanism of the thrombocytopenia in Scl-null mice. We show that Scl is a key regulator of platelet production, particularly during settings of haemopoietic stress.
The mechanism for this appears to be via direct regulation of NF-E2, as this factor is reduced in Scl-null platelets and its promoter is occupied by Scl in megakaryocytic cells. Scl -/Δ mice have approximately 50% normal peripheral blood platelet levels ( Figure   1A ). To examine the cause of thrombocytopenia in these mice, platelet survival was measured using in vivo biotinylation. This showed that the half-life of Scl -/Δ platelets was normal (57 hours) whilst the production of new, non-biotinylated platelets was significantly impaired ( Figure 1B ). The impaired platelet production was not explained by reduced megakaryocyte numbers as megakaryocyte numbers in the marrow of Scl -/Δ mice were normal ( Figure 1C ). In addition, megakaryocyte endomitosis as measured by DNA content (ploidy) was not impaired. Indeed, the ploidy of megakaryocytes from Scl -/Δ mice was significantly increased, with the modal ploidy elevated to 32N compared to the normal value of 16N ( Figure 1D ). Hence the defective platelet production in Scl -/Δ mice was not due to defects in megakaryocyte number or polyploidisation, and was most likely due to a defect in platelet release by mature megakaryocytes.
Defective response to thrombopoietin and 5FU in Scl -/Δ mice
The role of Scl in platelet production was further analysed in the setting of pharmacologic doses of thrombopoietin (TPO). This cytokine acts on megakaryocyte progenitors in the bone marrow to increase their number and maturation, subsequently leading to thrombocytosis in the blood 31 . Mice were administered with TPO for five consecutive days and platelet counts measured during the subsequent two weeks.
Strikingly, platelet levels in Scl -/Δ mice did not rise at any point during or following TPO administration (Figure 2A ). Thus Scl was required for thrombocytosis in response to TPO.
To confirm that the abnormal response to TPO was due to defective platelet production rather than increased destruction, platelet turnover was studied in Scl -/Δ mice in the setting of TPO treatment. Mice were treated with TPO for five days, as previously, with injection of NHS-biotin on the third day of TPO administration.
Platelet number and biotinylation were subsequently determined daily. Whilst loss of circulating, labelled platelets in TPO treated Scl +/Δ and Scl -/Δ mice displayed similar kinetics, the production of nascent, non-biotinylated platelets in TPO-treated Scl -/Δ mice was markedly reduced compared to that observed in the Scl +/Δ animals ( Figure   2B ), confirming that the absence of thrombocytosis in response to TPO was due to a defect in platelet production. Figure 2C ). We found that spleen megakaryocytes in long-term deleted Scl mice were normal, in contrast to the low levels seen previously in shortterm deleted mice 27 .
In addition to proliferation, TPO administration also promotes increased ploidisation of megakaryocytes via endomitosis. To assess the role of Scl in TPO-induced megakaryocyte endomitosis, mice were administered with TPO for four consecutive days and megakaryocyte ploidy assessed on day 5. The ploidy of megakaryocytes in Scl -/Δ mice increased to a similar extent to controls (modal ploidy shifting from 32N to 64N compared with 16N to 32N in controls) ( Figure 2D ). Hence the inability of Scl -/Δ mice to mount a thrombocytotic response TPO was not explained by defects in TPOinduced proliferation or endomitosis of megakaryocytes.
To examine the specificity of the abnormal TPO response, platelet recovery in Scl -/Δ mice was examined following treatment with the chemotherapeutic agent 5-fluorouracil (5FU). This drug ablates mature megakaryocytes and cycling progenitors leading to thrombocytopenia followed by a "rebound" thrombocytosis which occurs later than that induced by TPO, implying that it is derived from immature, noncycling progenitors such as haemopoietic stem cells 32 . Following 5FU treatment, platelet levels in control Scl +/Δ mice reduced to 35% of starting levels over 7 days,
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Other responses to 5FU such as leukocyte recovery were normal, indicating that this aberrant response was specific to the platelet lineage (data not shown).
Ultrastructural abnormalities of Scl -/Δ megakaryocytes
To further elucidate the mechanism of the defective platelet production in Scl Figure 3E ). Together, these results suggest that the platelet production defect of Scl -/Δ mice is due at least in part to defects in cytoplasmic platelets was a loss of elongated forms which are evidence of the normal discoid shape, indicating that the platelets were spherical, a finding which was confirmed using differential interference contrast microscopy ( Figure 4B , D). Other abnormalities included decreased numbers of both primary granules (an average of 1.9 per platelet versus 3.1 in controls) and dense granules (0.45 per platelet versus 0.71 in controls) and a corresponding increase in "depleted" granules (granules with little or no content, 1.7 per platelet compared with 1.0 in controls) defects which were mildly exacerbated following treatment of the mice with TPO (data not shown). There was also increased vacuolation of the cytoplasm ( Figure 4D ). Hence in addition to the platelet production defect present in Scl -/Δ mice, platelets produced by these mice were structurally abnormal.
Platelets from Scl -/Δ mice are functional
To test the haemostatic function of platelets in the absence of Scl, tail bleed assays were performed. There were slightly longer bleed times in Scl -/Δ mice, which may be due in part to the lower platelet count and hematocrit in these animals ( Figure 5A ). To further examine platelet function in the absence of Scl, in vitro platelet aggregation that Scl -/Δ platelets were functuional despite numerous structural abnormalities.
Defective gene expression in Scl -/Δ platelets
To examine the molecular basis for the defective platelet production in Scl -/Δ mice, the expression of several genes implicated in platelet shedding was studied. Large numbers of Scl -/Δ megakaryocytes for expression analysis could not be obtained because these cells do not grow or survive in vitro 27 , despite the normal in vivo response to TPO shown here. Therefore, purified platelets were used as a source of RNA for real-time PCR analysis. A small residual expression of Scl (≤10%) was found in some platelet RNA preparations from Scl -/Δ mice, however its presence did not appear to affect any of the phenotypes detailed in this study ( Figure 6A ). The NF-E2 transcription factor is critical for platelet shedding 9 . RT-PCR analysis revealed 8-fold reduced expression of NF-E2 in Scl -/Δ platelets ( Figure 6A ). Furthermore, β-1 tubulin, a proposed target gene of NF-E2 was reduced 10-fold in platelets derived from Scl -/Δ mice ( Figure 6A ). Of the other genes studied, Coagulation factor X, Calpain 2 and Platelet Factor 4 were only marginally reduced in Scl -/Δ platelets.
Interestingly, the expression of GATA-1 was reduced 2-fold, which is consistent with the binding of Scl to a tandem E-box GATA motif upstream of this gene 33 .
Expression of the TPO receptor, Mpl, was normal, indicating that abnormal platelet production in response to TPO was not due to reduced receptor expression.
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Scl binds the NF-E2 promoter in megakaryocytic cells
NF-E2 has been proposed to be regulated by GATA-1 binding to tandem GATA motifs located in the proximal 1b promoter located in the first intron of the gene 19, 20 .
Interestingly, an Scl DNA binding motif (E-Box) is located 10 base pairs from a GATA site within this motif ( Figure 6B ). To determine whether Scl can bind to the NF-E2 promoter, chromatin immonoprecipitation (ChIP) analysis was performed using antibodies directed against Scl, GATA-1 and other factors identified in a multimeric complex in erythroid cells 22 . Scl bound the NF-E2 promoter in the human megakaryoblastic cell line Meg-01 ( Figure 6C ). In addition, Lmo2, E47 and Ldb1
were also bound, suggesting the presence of a transcriptional complex. However, an
anti-GATA-1 antibody was unable to immunoprecipitate the NF-E2 promoter in Meg-01 cells, which may be due to the fact that this cell line is developmentally immature and expresses low levels of GATA-1 34 . However, we found that Meg-01 cells express high levels of GATA-2 protein by western blotting, and that GATA-2 protein bound to the NF-E2 promoter in these cells in the ChIP assay (data not shown, Figure   6D ).
To confirm that GATA-1 can bind the NF-E2 promoter, an identical ChIP assay was performed using the human erythroleukemic cell line K562, which has both erythroid and megakaryocytic potential, as these cells expresses higher levels of GATA-1. In these cells, GATA-1 was found to bind the NF-E2 promoter along with Scl, Lmo2, Ldb1 and E47 ( Figure 6E ). Thus GATA-1 and Scl both bind to the NF-E2
promoter in K562 cells. However, in immature megakaryocytic cells GATA-2 binds the promoter and not GATA-1.
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To examine the consequences of Scl binding to the NF-E2 promoter, the proximal 1b promoter region was cloned into a luciferase reporter construct and used in transient transfection experiments in HEK-293T cells along with expression vectors for the various transcription factors found associated with this promoter above. We found that whilst Scl and its partner proteins E12, Lmo2 and Ldb1 had no effect on transcription driven by the NF-E2 promoter, these factors were able to augment transcriptional activation of the promoter by GATA-1 ( Figure 6F ). This effect required Scl, however a DNA binding mutant of Scl (Δb) could substitute for Scl indicating that direct DNA binding by Scl was not required ( Figure 6F ).
The DNA binding region of Scl is not required NF-E2 promoter binding or platelet production
As the ability of Scl to promote transcriptional activation of the NF-E2 promoter did not require its DNA binding activity, we tested whether this region was required to bind the NF-E2 promoter region in K562 cells. After expression of haemagglutinin epitope (HA-) tagged Scl and Δb in these cells by retroviral vectors, the cells were subjected to ChIP assays using an anti-HA antibody. We found that both Scl and Δb were associated with the NF-E2 promoter at levels comparable with those obtained using and anti-E47 antibody ( Figure 7A ). Therefore, the DNA binding activity of Scl was not required to bind to the NF-E2 promoter.
To test whether the DNA-binding mutant of Scl is able to perform its functions in platelet production, mice were reconstituted with Scl-targeted (Scl -/loxP ) bone marrow infected with a GFP-encoding retroviral vector expressing the Δb mutant. Following reconstitution, recipient mice were treated with PIPC to remove Scl from the transplanted bone marrow (resulting in an Scl -/Δ genotype). After subsequent Figure 7B ). Therefore the DNA binding activity of Scl was not required for platelet production in response to TPO.
Discussion
The transcriptional regulation of megakaryocyte development, including platelet shedding, remains poorly understood. The most critical identified regulator is NF-E2, which is absolutely required during the terminal phase of platelet production 9 . Here we have used a conditionally deleted allele of Scl to demonstrate that this transcription factor is essential for platelet production from mature megakaryocytes, particularly in the setting of platelet recovery following the administration of the chemotherapeutic agent 5FU or in response to pharmacological doses of TPO. One role of Scl in platelet production appears to be regulation of NF-E2, as expression of NF-E2 was reduced 8-fold in the platelets of Scl -/Δ mice, Scl bound to the major NF-E2 promoter in megakaryocytic cells, and Scl could augment transcriptional activation of the NF-E2 promoter.
Defective platelet production in Scl -/Δ mice appears to be due to a late defect in megakaryocyte maturation as megakaryocyte numbers were normal and ploidy increased, but these showed a disordered demarcation membrane system and, following TPO administration, reduced platelet granules in the cytoplasm. These defects are similar to those seen in mice lacking NF-E2 9 . NF-E2 null megakaryocytes are unable to form proplatelets 11 , and we propose that this is also the mechanism for the reduced platelet production of Scl -/Δ mice, although we are unable to test this in vitro using the proplatelet assay due to a separate survival defect of Scl (Figure 2 ), the major functions of TPO in megakaryopoiesis, it is unlikely that Scl is an important target of TPO signalling.
Secondly, Scl function may be absolutely required for stress thrombopoiesis, whereas it is partially redundant in the resting state, or its loss is able to be compensated for.
Consequently, platelet production in Scl -/Δ mice may be at maximal capacity in the resting state, such that a stress response is not possible. Indeed, megakaryopoiesis in Scl -/Δ mice displayed several features of stress, including increased ploidy and large platelets. It may be that the reduced NF-E2 levels seen in Scl -/Δ mice are sufficient to produce the moderate platelet levels seen in the resting state, but insufficient to induce stress thrombocytosis.
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A key implication of this work is that NF-E2 is a direct target of Scl. This assertion is supported by three observations; that NF-E2 expression was markedly reduced in Scl Given that NF-E2 is a target of Scl and that NF-E2 knockout mice lack platelets almost entirely 9 , it is surprising that the thrombocytopenia seen in Scl -/Δ mice in the resting state was not more severe. The residual platelet formation in these mice is likely to be due to the low levels of NF-E2 still present in Scl -/Δ platelets (13%, Figure 6 ). This residual expression of NF-E2 is unlikely to be due to residual Scl expression, as similar platelet counts were found in mice in which no residual Scl expression could be detected (data not shown).
Alternatively, regulation of NF-E2 by other transcriptional mechanisms, or compensation for the loss of Scl by other basic helix-loop-helix transcription factors may account for the residual NF-E2 expression.
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NF-E2 is thought to be regulated by GATA-1, primarily through binding to a GATA-1 repeat sequence in the proximal intronic promoter 1b element of NF-E2 and consequently it has been inferred that these factors act in a linear fashion to regulate megakaryocyte development 8, 19, 20 . Whilst this has previously been studied using electrophoretic mobility shift assays, our finding that an anti-GATA- promoter, as has been shown in in vitro studies 22, 39 . This suggests a situation in which GATA-2 is replaced later in development by GATA-1, as has been shown in erythroid development 40 .
Interestingly, a DNA binding mutant of Scl could compensate for the major functions of Scl described in this study, namely, binding and transactivation of the NF-E2 promoter, and platelet production in response to TPO. Moreover, the E box sites present in the NF-E2 promoter are not consensus sites for Scl binding in conjunction with GATA factors (CAGGTG) 41 . These findings indicate that Scl may be recruited to the NF-E2 promoter by the binding of GATA factors to the tandem GATA motif present in this region.
Amongst the defined target genes of GATA-1 and NF-E2, is β-1 tubulin, a plateletspecific isoform of tubulin that is essential for normal platelet production and function. Loss of this factor leads to defective proplatelet formation, thombocytopenia and platelet spherocytosis 5, 6, 42 . Scl -/Δ platelets showed a severe reduction in β-1 tubulin expression, providing a molecular explanation for their spherocytosis, and resultant lack of shape change in response to thrombin (Figures 4 and 5) . Of the other
GATA-1 target genes tested, Coagulation factor X and Calpain 2 were only mildly affected, and Mpl and platelet factor 4 expression were not affected. This implies that Scl is not required for expression of all GATA-1 target genes in megakaryocyte development. This assertion is supported by the numerous differences in the megakaryocyte development of Scl -/Δ and GATA-1 deficient mice. Namely, GATA-1 deficient megakaryocytes are hyperproliferative in vitro and in vivo and are blocked in maturation, and GATA-1 deficient mice show a thrombocytopenia which is more severe than that observed in Scl -/Δ mice 16 .
Our findings indicate that Scl is critical for platelet production in response to thrombopoietin or 5-fluorouracil treatment. Future studies will aim to determine 27 . Mice were used for analysis greater than 1 month after treatment, at which point the haematological effects of PIPC treatment had resolved.
Haemopoietic analyses
For whole blood counts, 250 µl of blood was collected from the retroorbital plexus into tubes containing potassium EDTA (Sarstedt, Nümbrecht, Germany) and blood counts analyzed using an Avidia 120 automated hematological analyser (Bayer, Tarrytown, NY).
Stress thrombocytosis
To induce thrombocytosis, mice were injected with either 2 μg Pegylated 
Platelet turnover studies
Measurement of platelet lifespan was performed according to Ault and Knowles 45 .
Briefly, mice were injected twice, two hours apart, with 150 μl of 4 mg/ml biotin-Nhydroxysuccinamide (a 40 mg/ml stock solution in DMSO freshly diluted 1:10 in PBS). To measure the proportion of biotinylated platelets 1 μl blood was stained with anti-CD41-FITC and streptavidin APC (BD Pharmingen) and analysed by flow cytometry.
Measurement of megakaryocyte DNA content
Measurement of megakaryocyte DNA content was performed as described by Jackson et al. 46 . Briefly, bone marrow was flushed from femurs using CATCH buffer and stained with anti-CD41-FITC antibody (BD Pharmingen). Cells were resuspended in Hypotonic PI buffer (0.1% Sodium Citrate, 0.056% Sodium Chloride, 50 μg/ml
DNase free RNase A (Roche), 50 μg/ml Propidium Iodide (Sigma)) and analysed by flow cytometry. Large CD41 positive cells were gated and analysed for PI content. 
Tail Bleeding Studies
Tail bleeding times were performed in anaesthetised mice (sodium pentobarbitone) as described previously 47 . Briefly, a uniform incision 5mm long and 1mm deep was made using a template, 10 mm from the base of the tail. Bleeding was monitored every 30 seconds by blotting with filter paper, until cessation.
Platelet aggregation studies
Washed platelets (2.0 x10 8 /ml) prepared as previously described 47 were stimulated with the indicated concentration of agonist (thrombin) in the presence of calcium (1 mM). All aggregations were initiated by stirring the suspensions at 950 rpm for 10 min at 37 o C in a four-channel automated platelet analyzer (Packs 4, Haem).
Electron Microscopy
To analyse megakaryocytes using electron microscopy, mice were anesthetised before being perfused with 4 ml of warmed 2% glutaraldehyde, 2.5% paraformaldehyde in 0.1M sodium cacodylate buffer with 2mM calcium chloride, PBS, (pH 7.4) at a rate of 20.4ml/hr (Braun "perfusor compact S") into the descending aorta. The vena cava was cut to release pressure. The femurs were excised and immersion-fixed for a further 4 hr before rinsing in PBS and decalcifying the bone in 10% ethylenediaminetetracetic acid (EDTA) (pH 7.4) for 7 days at 4ºC. The bones were washed 3 times in PBS plus 5% sucrose for 15 min then post-fixed in 2% osmium tetroxide in PBS for 1 hour.
Washing in distilled water preceded dehydration through a graded series of ethanol (50%, 70%, 90%, 95%, 2 × 100%, 90 min each) before infiltration and embedding in Spurrs resin as per standard EM protocol. To analyse platelets, washed platelets isolated as above were fixed in 2% glutaraldehyde, 2.5% paraformaldehyde in PBS for 60 min at room temperature.
Following two washes in 0.08 M PBS, 5% sucrose, platelets were postfixed in 2% osmium tetroxide in 0.1M PBS for 60 min before processing into resin as above.
Dehydration steps were reduced to 15 min each.
Ultrathin sections were cut with a diamond knife (Diatome, Austria) using a Leica Ultracut S ultra-microtome (Austria) stained with both methanolic uranyl acetate and lead citrate before viewing in a transmission electron microscope, JEOL 1011 (Japan) at 60kV. Images were recorded with a MegaView III CCD cooled digital camera (Soft Imaging Systems, Münster, Germany). Platelet granularity was determined by visual examination of at least 100 platelets in each group.
RT-PCR
Platelets were purified as above from two mice in each group and used to generate total RNA using Trizol (Invitrogen). cDNA was generated using the Omniscript reverse transcriptase (Qiagen) according to the manufacturer's recommendations. 
Chromatin Immunoprecipitation
Chromatin immunoprecipitation assays were performed as described previously 48, 49 using antibodies directed against Scl (3014, a kind gift of Dr. C. Glenn Begley), Ldb1
(a kind gift of Dr. Jane Visvader), anti-HA (12CA5, Roche) and Lmo2 (N-16,), E47
(N-649), GATA-1 (N6) and GATA-2 (H-116 all from Santa Cruz Biotechnology).
Isolated DNA fragments were purified with a QIAquick spin kit (QIAGEN) and 2 μl from a 40 μl DNA extraction was amplified quantitatively by PCR using the following primers; forward 5'-GTTAACCTATGGCCCAAATGACCCT-3' and reverse 5'-AAGTTGTGGAAAGAGGCAAGCAGAC-3'. Where indicated the immunoprecipitated chromatin was quantitated by real-time PCR as above. were made up to a total of 750 ng using pEF-PGK-PURO. 48 hours post-transfection cell extracts were prepared and luciferase activity measured using the Dual Luciferase
Luciferase reporter assays
Reporter Assay System (Promega). Firefly luciferase activities were normalised to the corresponding levels of Renilla luciferase activity in each sample. Washed platelets derived from mice of the indicated Scl genotypes were stimulated with 0.5 U/ml thrombin (arrow), and aggregation monitored as described under 
Retrovirus production and bone marrow reconstitution
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